• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模拟表皮生长因子——表皮生长因子受体12结构域相互作用:对配体结合过程的启示

Modeling the epidermal growth factor -- epidermal growth factor receptor l2 domain interaction: implications for the ligand binding process.

作者信息

Jorissen Robert N, Treutlein Herbert R, Epa V Chandana, Burgess Antony W

机构信息

The Ludwig Institute for Cancer Research, Post Office Box 2008, Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia.

出版信息

J Biomol Struct Dyn. 2002 Jun;19(6):961-72. doi: 10.1080/07391102.2002.10506800.

DOI:10.1080/07391102.2002.10506800
PMID:12023799
Abstract

Signaling from the epidermal growth factor (EGF) receptor is triggered by the binding of ligands such as EGF or transforming growth factor alpha (TGF-alpha) and subsequent receptor dimerization. An understanding of these processes has been hindered by the lack of structural information about the ligand-bound, dimerized EGF receptor. Using an NMR-derived structure of EGF and a homology model of the major ligand binding domain of the EGF receptor and experimental data, we modeled the binding of EGF to this EGF receptor fragment. In this low resolution model of the complex, EGF sits across the second face of the EGF receptor L2 domain and EGF residues 10-16, 36-37, 40-47 bind to this face. The structural model is largely consistent with previously published NMR data describing the residues of TGF-alpha which interact strongly with the EGF receptor. Other EGF residues implicated in receptor binding are accounted by our proposal that the ligand binding is a two-step process with the EGF binding to at least one other site of the receptor. This three-dimensional model is expected to be useful in the design of ligand-based antagonists of the receptor.

摘要

表皮生长因子(EGF)受体的信号传导是由诸如EGF或转化生长因子α(TGF-α)等配体的结合以及随后的受体二聚化所触发的。由于缺乏关于配体结合的二聚化EGF受体的结构信息,对这些过程的理解受到了阻碍。利用通过核磁共振(NMR)获得的EGF结构、EGF受体主要配体结合结构域的同源模型以及实验数据,我们对EGF与该EGF受体片段的结合进行了建模。在这个低分辨率的复合物模型中,EGF位于EGF受体L2结构域的第二个面上,EGF的10 - 16、36 - 37、40 - 47位残基与该面结合。该结构模型在很大程度上与先前发表的描述与EGF受体强烈相互作用的TGF-α残基的NMR数据一致。我们提出配体结合是一个两步过程,其中EGF与受体的至少一个其他位点结合,这就解释了其他与受体结合有关的EGF残基。这个三维模型预计将有助于基于配体的受体拮抗剂的设计。

相似文献

1
Modeling the epidermal growth factor -- epidermal growth factor receptor l2 domain interaction: implications for the ligand binding process.模拟表皮生长因子——表皮生长因子受体12结构域相互作用:对配体结合过程的启示
J Biomol Struct Dyn. 2002 Jun;19(6):961-72. doi: 10.1080/07391102.2002.10506800.
2
Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor.表皮生长因子受体细胞外结构域比较模型的表征
Protein Sci. 2000 Feb;9(2):310-24. doi: 10.1110/ps.9.2.310.
3
Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.受体介导的对配体可用性的影响会影响表皮生长因子和转化生长因子α的相对促有丝分裂能力。
J Cell Physiol. 1996 Mar;166(3):512-22. doi: 10.1002/(SICI)1097-4652(199603)166:3<512::AID-JCP6>3.0.CO;2-S.
4
Ligand binding characterization and molecular analysis of distinct epidermal growth factor-urogastrone receptors in cultured smooth muscle and epithelial cells from guinea pig intestine.豚鼠肠道平滑肌和上皮细胞中不同表皮生长因子-尿抑胃素受体的配体结合特性及分子分析
Mol Pharmacol. 1994 Aug;46(2):256-65.
5
The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.致癌性表皮生长因子受体2/表皮生长因子受体3异二聚体是表皮生长因子和β细胞素的替代受体。
Oncogene. 1998 Mar 12;16(10):1249-58. doi: 10.1038/sj.onc.1201642.
6
A model for the activation of the epidermal growth factor receptor kinase involvement of an asymmetric dimer?表皮生长因子受体激酶激活的模型:不对称二聚体的参与?
Biochemistry. 1997 Apr 1;36(13):3826-36. doi: 10.1021/bi9614141.
7
Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity.腱生蛋白细胞趋化蛋白表皮生长因子样重复序列以低亲和力结合表皮生长因子受体。
J Cell Physiol. 2007 Jun;211(3):748-58. doi: 10.1002/jcp.20986.
8
Structure-function studies of ligand-induced epidermal growth factor receptor dimerization.配体诱导的表皮生长因子受体二聚化的结构-功能研究
Biochemistry. 1998 Apr 7;37(14):4884-91. doi: 10.1021/bi972548x.
9
The coupling between transforming growth factor-alpha and the epidermal growth factor receptor during rat liver regeneration.大鼠肝脏再生过程中转化生长因子-α与表皮生长因子受体之间的偶联
Exp Cell Res. 1993 Feb;204(2):321-8. doi: 10.1006/excr.1993.1039.
10
Persistence of dimerization and enzymatic activity of epidermal growth factor receptor in the absence of epidermal growth factor.在缺乏表皮生长因子的情况下表皮生长因子受体二聚化和酶活性的持续性
Biochemistry. 1997 Dec 2;36(48):14889-96. doi: 10.1021/bi9706834.

引用本文的文献

1
VEGF receptor heterodimers and homodimers are differentially expressed in neuronal and endothelial cell types.VEGF 受体异二聚体和同二聚体在神经元和内皮细胞类型中呈现差异性表达。
PLoS One. 2022 Jul 21;17(7):e0269818. doi: 10.1371/journal.pone.0269818. eCollection 2022.
2
The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis.VEGFR-1 和 VEGFR-2 异二聚化在调节内皮细胞稳态中的作用。
Nat Commun. 2012 Jul 24;3:972. doi: 10.1038/ncomms1977.
3
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer.
吉非替尼用于难治性或复发性上皮性卵巢癌患者的II期药效学研究。
Cancer. 2007 Apr 1;109(7):1323-30. doi: 10.1002/cncr.22545.